[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BIOTECHSCANNER BIOTECH SCANNER BIOTECH SCANNER posts on X about $iova, $aqst, china, fud the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1408278003109466115/interactions)  - X Week XXXXX +1.80% - X Month XXXXXX -XX% - X Months XXXXXXX +3.50% - X Year XXXXXXXXX -XX% ### Mentions: X [#](/creator/twitter::1408278003109466115/posts_active)  - X Week X -XX% - X Month XXX -XX% - X Months XXX +31% - X Year XXXXX -XXXX% ### Followers: XXXXX [#](/creator/twitter::1408278003109466115/followers)  - X Week XXXXX +0.28% - X Month XXXXX +0.17% - X Months XXXXX +6.80% - X Year XXXXX +9.20% ### CreatorRank: XXXXXXX [#](/creator/twitter::1408278003109466115/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XXXXX% [countries](/list/countries) XXXX% **Social topic influence** [$iova](/topic/$iova) #5, [$aqst](/topic/$aqst) #1, [china](/topic/china) 7.69%, [fud](/topic/fud) 7.69%, [market cap](/topic/market-cap) 7.69%, [ceo](/topic/ceo) 7.69%, [health](/topic/health) 7.69%, [skin](/topic/skin) 7.69%, [$arqt](/topic/$arqt) 7.69%, [foam](/topic/foam) XXXX% **Top accounts mentioned or mentioned by** [@chuck80339031](/creator/undefined) [@iovancebio](/creator/undefined) [@targetedonc](/creator/undefined) [@therealdansfera](/creator/undefined) [@mucosalmelanoma](/creator/undefined) [@volstki](/creator/undefined) [@hensley1552](/creator/undefined) [@darrenestes](/creator/undefined) [@dansfera](/creator/undefined) [@salmonstockcar](/creator/undefined) [@henry431171040](/creator/undefined) **Top assets mentioned** [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Arcutis Biotherapeutics, Inc. Common Stock (ARQT)](/topic/$arqt) ### Top Social Posts Top posts by engagements in the last XX hours "@Chuck80339031 $IOVA is a unicorn. 2026 and beyond will be very exciting starting in the 2H of 2026" [X Link](https://x.com/BIOTECHSCANNER/status/1997690340678283406) 2025-12-07T15:31Z 7603 followers, XXX engagements "$AQST $IOVA - This is a big surprise to me. I thought Dr. Richard Pazdur the new director of the Center for Drug Evaluation and Research (CDER) would be on board with the National Priority Voucher program. Apparently not" [X Link](https://x.com/BIOTECHSCANNER/status/1993348199286030714) 2025-11-25T15:56Z 7593 followers, 5734 engagements "@TheRealDanSfera Why are people investing in companies doing trials in China is beyond me. Duh" [X Link](https://x.com/BIOTECHSCANNER/status/1990884724781318598) 2025-11-18T20:48Z 7600 followers, XXX engagements "$AQST - Sad to see Dr. Carl Kraus at another company but definitely wishing him the best" [X Link](https://x.com/BIOTECHSCANNER/status/1993696435838038307) 2025-11-26T15:00Z 7603 followers, 3368 engagements "$IOVA - Someone show this short to the nearest Goodwill store. He was warned. X day before earnings came out he was scared so he does what shorts do when they get scared- spreading FUD (Fear Uncertainty Doubt). Hes living with all three in a van by the river 😂. Hope he covered. If not it will get ugly for him fast" [X Link](https://x.com/BIOTECHSCANNER/status/1986679024400162827) 2025-11-07T06:16Z 7602 followers, 5264 engagements "How to identify great biotech companies. Also my track record below. X. Undervalued (low market cap vs assets and market potential) X. Solid management (biotech experience CEO track record and reputation not too many turnovers) X. Great pipeline versus whats currently available (look for first and only or best in class potential. X. Solving a big unmet need X. Incremental successes through various stages of clinical trials X. Strong upcoming catalysts X. Positive interactions with FDA X. Buyout or partnership potential X. Similar compounds performing successfully on the market XX. Current" [X Link](https://x.com/BIOTECHSCANNER/status/1810008082837119416) 2024-07-07T17:48Z 7602 followers, 199.2K engagements "$IOVA - Keep in mind that next quarter Q4 is the beginning of the integration of InspiroGene as a HUB for community hospitals and all ATCs if they choose to use them as a specialty pharmacy. They are crazy if they didnt. This will unclog referral and reimbursement bottlenecks. Q4 is when I will expect to see meaningful revenue and margin improvements. For this quarter Q3 I will take anything from $60M to $70M. Remember the partnership with InspiroGene by McKesson was announced late September and it takes a while to incorporate everything. PATIENCE" [X Link](https://x.com/BIOTECHSCANNER/status/1986159659389231479) 2025-11-05T19:52Z 7602 followers, 4164 engagements "$AQST $IOVA - Good morning 🐉 family. You may have noticed that I have been very quiet lately and its intentional. First this is a very quiet period especially for $IOVA and $AQST. Second I have been very busy with a personal health scare related to my daughter. While vacationing in Vietnam this past summer she told us about a growth on her skin in near the area that she was too embarrassed to share. Because of that it kept growing to a large mole like growth. Now put yourself in my shoes especially what I have talked about here as it relates to possible skin cancer. This kinda tampered our" [X Link](https://x.com/BIOTECHSCANNER/status/1997345020731404685) 2025-12-06T16:38Z 7603 followers, 5015 engagements "$ARQT - I am so happy for shareholders. This has turned out to be one of the biggest calls that I made. I predicted in May of 2024 X months before Zoryve foam was approved for atopic dermatitis on July X 2024. The share price was about $XXXX in May of 2024 and today its $XXXXX. Zoryve approval is part of my 6-0 PDUFA record. Why was I so confident that Zoryve would be approved BECAUSE I HAVE WORKED WITH THE DRUG BEFORE. ZORYVE (roflumilast) belongs to the phosphodiesterase4 (PDE4) inhibitor class of drugs. Before being used to treat psoriasis roflumilast was used to treat COPD exacerbations" [X Link](https://x.com/BIOTECHSCANNER/status/1997713873961357711) 2025-12-07T17:04Z 7603 followers, 3814 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BIOTECHSCANNER BIOTECH SCANNER
BIOTECH SCANNER posts on X about $iova, $aqst, china, fud the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX +1.80%
- X Month XXXXXX -XX%
- X Months XXXXXXX +3.50%
- X Year XXXXXXXXX -XX%
Mentions: X #
- X Week X -XX%
- X Month XXX -XX%
- X Months XXX +31%
- X Year XXXXX -XXXX%
Followers: XXXXX #
- X Week XXXXX +0.28%
- X Month XXXXX +0.17%
- X Months XXXXX +6.80%
- X Year XXXXX +9.20%
CreatorRank: XXXXXXX #
Social Influence
Social category influence finance XXXXX% countries XXXX%
Social topic influence $iova #5, $aqst #1, china 7.69%, fud 7.69%, market cap 7.69%, ceo 7.69%, health 7.69%, skin 7.69%, $arqt 7.69%, foam XXXX%
Top accounts mentioned or mentioned by @chuck80339031 @iovancebio @targetedonc @therealdansfera @mucosalmelanoma @volstki @hensley1552 @darrenestes @dansfera @salmonstockcar @henry431171040
Top assets mentioned Iovance Biotherapeutics, Inc. Common Stock (IOVA) Arcutis Biotherapeutics, Inc. Common Stock (ARQT)
Top Social Posts
Top posts by engagements in the last XX hours
"@Chuck80339031 $IOVA is a unicorn. 2026 and beyond will be very exciting starting in the 2H of 2026"
X Link 2025-12-07T15:31Z 7603 followers, XXX engagements
"$AQST $IOVA - This is a big surprise to me. I thought Dr. Richard Pazdur the new director of the Center for Drug Evaluation and Research (CDER) would be on board with the National Priority Voucher program. Apparently not"
X Link 2025-11-25T15:56Z 7593 followers, 5734 engagements
"@TheRealDanSfera Why are people investing in companies doing trials in China is beyond me. Duh"
X Link 2025-11-18T20:48Z 7600 followers, XXX engagements
"$AQST - Sad to see Dr. Carl Kraus at another company but definitely wishing him the best"
X Link 2025-11-26T15:00Z 7603 followers, 3368 engagements
"$IOVA - Someone show this short to the nearest Goodwill store. He was warned. X day before earnings came out he was scared so he does what shorts do when they get scared- spreading FUD (Fear Uncertainty Doubt). Hes living with all three in a van by the river 😂. Hope he covered. If not it will get ugly for him fast"
X Link 2025-11-07T06:16Z 7602 followers, 5264 engagements
"How to identify great biotech companies. Also my track record below. X. Undervalued (low market cap vs assets and market potential) X. Solid management (biotech experience CEO track record and reputation not too many turnovers) X. Great pipeline versus whats currently available (look for first and only or best in class potential. X. Solving a big unmet need X. Incremental successes through various stages of clinical trials X. Strong upcoming catalysts X. Positive interactions with FDA X. Buyout or partnership potential X. Similar compounds performing successfully on the market XX. Current"
X Link 2024-07-07T17:48Z 7602 followers, 199.2K engagements
"$IOVA - Keep in mind that next quarter Q4 is the beginning of the integration of InspiroGene as a HUB for community hospitals and all ATCs if they choose to use them as a specialty pharmacy. They are crazy if they didnt. This will unclog referral and reimbursement bottlenecks. Q4 is when I will expect to see meaningful revenue and margin improvements. For this quarter Q3 I will take anything from $60M to $70M. Remember the partnership with InspiroGene by McKesson was announced late September and it takes a while to incorporate everything. PATIENCE"
X Link 2025-11-05T19:52Z 7602 followers, 4164 engagements
"$AQST $IOVA - Good morning 🐉 family. You may have noticed that I have been very quiet lately and its intentional. First this is a very quiet period especially for $IOVA and $AQST. Second I have been very busy with a personal health scare related to my daughter. While vacationing in Vietnam this past summer she told us about a growth on her skin in near the area that she was too embarrassed to share. Because of that it kept growing to a large mole like growth. Now put yourself in my shoes especially what I have talked about here as it relates to possible skin cancer. This kinda tampered our"
X Link 2025-12-06T16:38Z 7603 followers, 5015 engagements
"$ARQT - I am so happy for shareholders. This has turned out to be one of the biggest calls that I made. I predicted in May of 2024 X months before Zoryve foam was approved for atopic dermatitis on July X 2024. The share price was about $XXXX in May of 2024 and today its $XXXXX. Zoryve approval is part of my 6-0 PDUFA record. Why was I so confident that Zoryve would be approved BECAUSE I HAVE WORKED WITH THE DRUG BEFORE. ZORYVE (roflumilast) belongs to the phosphodiesterase4 (PDE4) inhibitor class of drugs. Before being used to treat psoriasis roflumilast was used to treat COPD exacerbations"
X Link 2025-12-07T17:04Z 7603 followers, 3814 engagements